| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 167,042 | 150,432 | 117,422 | 108,306 | | Cost of Revenue | 56,580 | 63,590 | 48,361 | 75,024 | | | Gross Profit | 110,462 | 86,842 | 69,061 | 33,282 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,370 | 11,191 | 11,828 | 29,395 | | Non Recurring | 28,761 | (5,175) | 210,205 | 1,161,861 | | Others | 59,312 | 84,595 | 91,535 | 108,581 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,322 | (3,769) | (244,507) | (1,266,555) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,658) | (2,708) | 505 | 4,101 | | Earnings Before Interest And Taxes | 7,361 | (6,477) | (244,002) | (1,262,454) | | Interest Expense | 9,222 | 10,018 | 10,727 | 9,539 | | Income Before Tax | (1,861) | (16,495) | (254,729) | (1,271,993) | | Income Tax Expense | (539) | (10,521) | (23,992) | (420,577) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,248) | (5,974) | (230,737) | (851,416) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,322) | (5,974) | (230,737) | (851,416) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,322) | ($5,974) | ($230,737) | ($851,416) |
|
0.02% Nasdaq 0.00%
Income Statement
